RG
Ravi Gendalal Mewade
Active Director Designated Partner DIN 09147250
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Apr 2021
Shareholding value β’β’β’β’ Premium profile
About Ravi Gendalal Mewade
Data last updated:
Ravi Gendalal Mewade is a Designated Partner at Purple Mark Pharmaceuticals Llp (since 2021). The company operates in Chemicals.
DIN 09147250
Primary Designation Designated Partner
Industry Chemicals
First Appointment 15 Apr 2021
Oldest Company Age 5 yrs
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Designated Partner | 15 Apr 2021 | 2021 | Active |
Board colleagues of Ravi Gendalal Mewade
| Name | DIN | Company | Designation |
|---|---|---|---|
| Ritesh Mewade | 09147251 | Purple Mark Pharmaceuticals Llp | Designated Partner |
Directorship timeline
Open interactive timeline →Purple Mark Pharmaceuticals Llp
Premium access
Shareholding and investment profile for Ravi Gendalal Mewade
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Ravi Gendalal Mewade
Ravi Gendalal Mewade currently holds 1 directorship: Purple Mark Pharmaceuticals Llp (Designated Partner, since 15 Apr 2021).
Ravi Gendalal Mewade was first appointed on 15 Apr 2021 as Designated Partner at Purple Mark Pharmaceuticals Llp.
The current boards of Ravi Gendalal Mewade's companies include Ritesh Mewade (Purple Mark Pharmaceuticals Llp).